DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zemaira (Alpha 1-Antitrypsin) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Zemaira (Alpha 1-Antitrypsin) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (57)
Death (1)

Reports by Reaction Type

Dyspnoea (13)Infusion Related Reaction (12)Dizziness (8)Chills (7)Fatigue (7)Pneumonia (6)Respiratory Tract Infection (6)Chronic Obstructive Pulmonary Disease (5)Upper Respiratory Tract Infection (5)Sinusitis (5)Condition Aggravated (5)Bone Pain (4)

Below are a few examples of reports where side effects / adverse reactions may be related to Zemaira (Alpha 1-Antitrypsin). For a complete list or a specific selection of reports, please use the links above.

Possible Zemaira side effects in male

Reported by a physician from United States on 2012-08-15

Patient: male, weighing 113.4 kg (249.5 pounds)

Reactions: Dyspnoea, Chills, Blood Pressure Decreased, Hyperhidrosis, Hypertension, Oxygen Saturation Decreased

Drug(s) suspected as cause:
Zemaira

Other drugs received by patient: Banophen (Diphenhydramine Hydrochloride); Centrum Ultra MEN (Centrm / 00554501 / ); Zyrtec; Hydrochlorothiazide; Celebrex; Lipitor; Lisinopril



Possible Zemaira side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-15

Patient: female

Reactions: Respiratory Tract Infection

Drug(s) suspected as cause:
Zemaira



Possible Zemaira side effects in 45 year old female

Reported by a pharmacist from United States on 2012-08-13

Patient: 45 year old female, weighing 104.3 kg (229.5 pounds)

Reactions: Tooth Loss, Weight Decreased, Anxiety, Dyspnoea, Vomiting, Nausea, Pulmonary Arterial Hypertension, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira
    Dosage: (60 mg/kg 1x/week, 953 mg vial intravenous (not otherwise specified))
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2009-01-01

Zemaira
    Dosage: (60 mg/kg 1x/week, 953 mg vial intravenous (not otherwise specified))
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2012-03-01
    End date: 2012-03-01

Other drugs received by patient: Biotin; Xopenex; Singulair; Oxygen; Symbicort; Vitamin D; Digestive Probiotic (Lactobacillus Acidophilus); Alprazolam; Xanax; Protonix; Ipratropium Bromide; Albuterol; Codeine Sulfate; Combivent; Levothyroxine Sodium



Possible Zemaira side effects in female

Reported by a individual with unspecified qualification from United States on 2012-08-06

Patient: female

Reactions: Chills, Pyrexia, Device Related Infection

Drug(s) suspected as cause:
Zemaira

Aralast Alpha-1-Antitrypsin)
    Start date: 2010-06-01
    End date: 2010-08-01



Possible Zemaira side effects in male

Reported by a physician from United States on 2012-07-19

Patient: male

Reactions: Dizziness, Blood Glucose Increased

Drug(s) suspected as cause:
Zemaira

Other drugs received by patient: Spiriva; Darvocet-N 100; Robitussin DM (Robitussin); Zyrtec; Tylenol P (Paracetamol); Albuterol; Singulair; Lidoderm; Zetia; Advair HFA



Possible Zemaira side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-16

Patient: male

Reactions: Lung Disorder, Dizziness, Unevaluable Event, Blood Glucose Increased

Drug(s) suspected as cause:
Zemaira



Possible Zemaira side effects in

Reported by a individual with unspecified qualification from United States on 2012-07-06

Patient:

Reactions: Circumstance or Information Capable of Leading To Medication Error, Medication Error, Product Packaging Quantity Issue

Drug(s) suspected as cause:
Zemaira



Possible Zemaira side effects in 40 year old female

Reported by a pharmacist from United States on 2012-07-06

Patient: 40 year old female, weighing 59.0 kg (129.7 pounds)

Reactions: Product Colour Issue, Discomfort, Infusion Related Reaction

Drug(s) suspected as cause:
Zemaira



Possible Zemaira side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-02

Patient: female

Reactions: Chills, Device Related Infection, Pyrexia

Drug(s) suspected as cause:
Zemaira
    Start date: 2010-08-01

Aralast NP
    Start date: 2010-07-01
    End date: 2010-08-01



Possible Zemaira side effects in 54 year old female

Reported by a physician from United States on 2012-05-29

Patient: 54 year old female, weighing 72.6 kg (159.7 pounds)

Reactions: Hospitalisation, Adverse Event

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira

Other drugs received by patient: Benadryl; Trazodone HCL; Multivitamin (Multivitamin / 00831701 / ); Lamictal; Sodium Chloride 0.9%; Fluoxetine



Possible Zemaira side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-15

Patient: female

Reactions: Chest Discomfort, Pneumonia, Dyspnoea, Muscle Spasms

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira



Possible Zemaira side effects in 53 year old female

Reported by a consumer/non-health professional from United States on 2012-05-03

Patient: 53 year old female

Reactions: Hyperventilation, Dyspnoea, Paraesthesia

Drug(s) suspected as cause:
Zemaira



Possible Zemaira side effects in male

Reported by a physician from United States on 2012-04-23

Patient: male, weighing 97.5 kg (214.6 pounds)

Reactions: Vomiting, Nausea, Peritoneal Dialysis, Headache, Infusion Related Reaction

Drug(s) suspected as cause:
Zemaira
    Indication: Alpha-1 Anti-Trypsin Deficiency

Zemaira
    Dosage: 80 mg/kg 1x/week, 990 mg vial intravenous (not otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency

Zemaira
    Indication: Alpha-1 Anti-Trypsin Deficiency

Zemaira
    Dosage: 80 mg/kg 1x/week, 80 mg/kg weekly 15 minute total infusion time intravenous (not otherwise specifie
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2009-05-20

Other drugs received by patient: Cellcept; Folic Acid; Protonix; Amitriptyline HCL (Amitriptyline); Oxycodone HCL and Acetaminophen; Lantis (Insulin Glargine); BL Ferrous SU (Ferrous Sulfate); Prograff (Tacrolimus); Prochlorperazine; Prednisone; Calcium 600 D (Calcium with Vitamin D); Actos; Humalog; Lisinopril; Sodium Bicarbonate; Glipizide; Simvastatin



Possible Zemaira side effects in 61 year old female

Reported by a pharmacist from United States on 2012-04-02

Patient: 61 year old female, weighing 143.8 kg (316.3 pounds)

Reactions: Pneumonia, Cellulitis, Concomitant Disease Aggravated, Chronic Respiratory Failure, Chronic Obstructive Pulmonary Disease, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira
    Dosage: (952 mg/vial; 952 mg/20 ml intravenous (not otherwise specified))
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2012-01-01

Zemaira
    Dosage: (952 mg/vial; 952 mg/20 ml intravenous (not otherwise specified))
    Indication: Emphysema
    Start date: 2012-01-01

Zemaira
    Dosage: (60 mg/kg 1x/week, 945 mg/vial;max rate=0.08 ml/kg/min (11.6 ml/min) intravenous (not otherwise spe
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2007-01-01

Zemaira
    Dosage: (60 mg/kg 1x/week, 945 mg/vial;max rate=0.08 ml/kg/min (11.6 ml/min) intravenous (not otherwise spe
    Indication: Emphysema
    Start date: 2007-01-01

Zemaira
    Indication: Emphysema
    Start date: 2012-03-14

Zemaira
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2012-03-14

Other drugs received by patient: Sodium Chloride; Singulair; Vitamin D; Lasix; Prinzide; Cardizem; Zocor; Metformin HCL; Advair HFA; Ibuprofen (Advil); Multivitamin (Accomin Multivitamin); Ipratropium Albuterol (Salbutamol W / Ipratropium)



Possible Zemaira side effects in 54 year old female

Reported by a physician from United States on 2012-03-15

Patient: 54 year old female, weighing 78.9 kg (173.6 pounds)

Reactions: Productive Cough, Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira
    Indication: Alpha-1 Anti-Trypsin Deficiency

Zemaira
    Dosage: 60 mg/kg 1x/week, at rate of 0.08 ml per kg per minute intravenous (not otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2010-04-01

Zemaira
    Dosage: 60 mg/kg 1x/week, 0.08 ml /kg/min intravenous (not otherwise specified))
    Start date: 2012-02-28

Other drugs received by patient: Thiamine HCL; Pulmicort; Singulair; Multivitamin (Daily Multivitamin); Foradil; Albuterol; Protonix; Zaroxolyn; Heparin; Nexium; Prednisone TAB; Lasix (Insulin Glargine); Diltiazem HCL; Lantus; Flexeril; Spiriva; Vitamin B12 (Cyanocobalamin-Tannin Complex); Digoxin; Doxycycline



Possible Zemaira side effects in 54 year old female

Reported by a pharmacist from United States on 2012-03-14

Patient: 54 year old female, weighing 72.6 kg (159.7 pounds)

Reactions: Hospitalisation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira

Other drugs received by patient: Trazodone HCL; Benadryl; Fluoxetine; Sodium Chloride; Multi-Vitamin; Lamictal



Possible Zemaira side effects in 58 year old female

Reported by a pharmacist from United States on 2012-03-14

Patient: 58 year old female, weighing 82.0 kg (180.4 pounds)

Reactions: Cellulitis, Sinusitis, Respiratory Tract Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira
    Dosage: intravenous (not otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-06-01

Zemaira
    Dosage: 60 mg/kg 1x/week intravenous otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency

Zemaira
    Dosage: 60 mg/kg 1x/week intravenous (not otherwise specified,
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2007-02-01

Zemaira
    Dosage: intravenous (not otherwise specified
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-04-01

Zemaira
    Dosage: 869 mg vial; max rate of 0.08 ml./kg/min (3 ml/min) intravenous (not otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency

Zemaira
    Dosage: 60 mg/kg 1x/week
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2007-01-01

Other drugs received by patient: Oxygen; Aspirin; Lutein (Xantofyl); Fosamax; Prednisone; Azmacort Inhaler (Triamcinolone Acetonide); Xanax; Sodium Chloride; Albuterol; Ibuprofen; Multivitamin (Accomin Multivitamin); Spiriva; Acetaminophen; Pneumovax 23; Doxycycline Hyclate



Possible Zemaira side effects in 49 year old female

Reported by a pharmacist from United States on 2012-03-14

Patient: 49 year old female, weighing 62.6 kg (137.7 pounds)

Reactions: Fatigue, Upper Respiratory Tract Infection, Pulmonary Arterial Hypertension, Somnolence, Respiratory Tract Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira
    Dosage: 60 mg/kg 1x/7 days intravenous (not otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2009-11-01

Zemaira
    Dosage: intravenous (not otherwise specified))
    Indication: Alpha-1 Anti-Trypsin Deficiency

Other drugs received by patient: Sodium Chloride; Doxepin HCL; Xopenex HFA (Levosalbutamol); Zyban; Estradiol; Lisinopril; Oxygen; Spiriva; Prednisone TAB; Advair 250 (Seretide); Albuterol



Possible Zemaira side effects in male

Reported by a pharmacist from United States on 2012-03-02

Patient: male, weighing 73.5 kg (161.7 pounds)

Reactions: Asthma, Respiratory Tract Congestion, Chest Pain, Oxygen Saturation Decreased

Drug(s) suspected as cause:
Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2010-01-01

Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2010-01-01

Zemaira

Other drugs received by patient: Zyrtec; Singulair; Sodium Chloride 0.9%; Prednisone TAB; Flovent; Spiriva; Nasacort; Levaquin



Possible Zemaira side effects in 61 year old female

Reported by a pharmacist from United States on 2012-02-15

Patient: 61 year old female, weighing 144.7 kg (318.3 pounds)

Reactions: Pneumonia, Cellulitis, Condition Aggravated, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira

Zemaira
    Dosage: 60 mg/kg 1/week, 945 mg/vial, max rate = 0.08 ml/kg/min (11.6 ml /min intravenous (not otherwise spe
    Indication: Emphysema

Zemaira
    Dosage: 60 mg/kg 1/week, 945 mg/vial, max rate = 0.08 ml/kg/min (11.6 ml /min intravenous (not otherwise spe
    Indication: Alpha-1 Anti-Trypsin Deficiency

Other drugs received by patient: Sodium Chloride 0.9%; Singulair; Cardizem; Oxygen (Oxygen); Ibuprofen (Advil); Lasix; Advair HFA; Multivitamin (Accomin Multivitamin); Vitamin D; Ipratropium Albuterol (Salbutamol W / Ipratropium); Zocor; Metformin HCL; Prinzide



Possible Zemaira side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-15

Patient: 58 year old female, weighing 82.0 kg (180.4 pounds)

Reactions: Cellulitis, Skin Infection, Respiratory Tract Infection, Sinusitis

Drug(s) suspected as cause:
Zemaira
    Dosage: 60;869;0.08; 3mg 1xweek, intravenous
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-04-01

Zemaira
    Dosage: 60;869;0.08; 3mg 1xweek, intravenous
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2007-02-01

Zemaira
    Dosage: 60;869;0.08; 3mg 1xweek, intravenous
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-06-01

Zemaira
    Dosage: 60;869;0.08; 3mg 1xweek, intravenous
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2007-01-01

Zemaira

Zemaira

Other drugs received by patient: Fosamax; Prednisone TAB; Albuterol; Xanax; Pneumovax 23; Ibuprofen; Multivitamin (Accomin Multivitamin); Azmacort Inhaler (Triamcinolone Acetonide; Lutein (Xantofyl); Oxygen (Oxygen); Spiriva; Acetaminophen; Aspirin; Sodium Chloride 0.9%



Possible Zemaira side effects in 61 year old female

Reported by a physician from United States on 2012-01-23

Patient: 61 year old female, weighing 91.2 kg (200.6 pounds)

Reactions: Contusion, Angioedema, Pain in Extremity, Condition Aggravated, Nasal Congestion, Musculoskeletal Chest Pain, Headache, Oral Pruritus, Fall, Oral Discomfort, Pruritus Generalised, Fatigue, Limb Injury, Dizziness, Infusion Related Reaction

Drug(s) suspected as cause:
Zemaira

Zemaira

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-01-26

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-01-26

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-03-31

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-03-31

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-02-20

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-02-20

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-05-05

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-05-05

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-01-28

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-01-28

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-01-26

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-01-26

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2010-11-01

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2010-11-01

Zemaira

Zemaira

Zemaira

Other drugs received by patient: Novolog; Protonix; Sodium Chloride 0.9%; Ibuprofen; Xanax; Levothyroxine Sodium; Vitamin B12; Novolog; Celexa; Lantus; Atenolol; Albuterol; Multivitamin (Accomin Multivitamin); Vitamin D; Gabapentin; Cardizem



Possible Zemaira side effects in 56 year old female

Reported by a physician from United States on 2012-01-23

Patient: 56 year old female, weighing 72.6 kg (159.7 pounds)

Reactions: Respiratory Tract Congestion, Viral Upper Respiratory Tract Infection, Nasopharyngitis, Condition Aggravated, Sinusitis, Chronic Obstructive Pulmonary Disease, Lower Respiratory Tract Infection

Drug(s) suspected as cause:
Zemaira
    Dosage: see image
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-10-13

Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-10-13

Zemaira
    Dosage: see image
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2012-01-05

Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2012-01-05

Zemaira
    Dosage: see image
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2009-08-01

Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2009-08-01

Zemaira

Zemaira

Zemaira

Other drugs received by patient: Mucinex; Singulair; Lisinopril; Advair Diskus 100 / 50; Lexapro; Estrace; PRO AIR (Procaterol Hydrochloride); Prinivil; Spiriva; Activella (Oestranorm)



Possible Zemaira side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-20

Patient: male, weighing 110.0 kg (242.0 pounds)

Reactions: Chest Discomfort, Pharyngeal Disorder, Dizziness, Headache, Infusion Related Reaction

Drug(s) suspected as cause:
Zemaira

Other drugs received by patient: Ascorbic Acid; Losartan Potassium; Symbicort; Combivent; PRE MED Benadril; Amlodipine



Possible Zemaira side effects in 56 year old female

Reported by a physician from United States on 2012-01-18

Patient: 56 year old female, weighing 72.6 kg (159.7 pounds)

Reactions: Upper Respiratory Tract Infection, Sinusitis

Drug(s) suspected as cause:
Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2009-08-01

Zemaira
    Dosage: see image
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2009-08-01

Zemaira

Zemaira

Zemaira

Other drugs received by patient: Singulair; PRO AIR (Procaterol Hydrochloride); Advair HFA; Prinivil; Mucinex; Lexapro; Spiriva; Activella (Oestranorm); Estrace; Lisinopril



Possible Zemaira side effects in 68 year old female

Reported by a pharmacist from United States on 2012-01-18

Patient: 68 year old female, weighing 66.2 kg (145.7 pounds)

Reactions: Vomiting, Nausea, Lower Respiratory Tract Infection, Infusion Related Reaction

Drug(s) suspected as cause:
Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2010-11-22

Zemaira
    Dosage: see image
    Indication: Emphysema
    Start date: 2010-11-22

Zemaira
    Start date: 2010-11-22

Zemaira
    Start date: 2010-11-22

Other drugs received by patient: Calan; Benzonatate; Xanax; Advair HFA; Orphenadrine Citrate; Zyrtec; Pravastatin; Lyrica; Avapro; Maxzide; Oxygen; Multivitamin Accomin Multivitamin); Sodium Chloride; Albuterol



Possible Zemaira side effects in 50 year old female

Reported by a pharmacist from United States on 2012-01-18

Patient: 50 year old female, weighing 45.4 kg (99.8 pounds)

Reactions: Lung Infection

Drug(s) suspected as cause:
Zemaira
    Dosage: (60 mg/kg 1x/week,869 mg/20 ml vial;0.08 ml/kg/min(3.7 ml/min.) intravenous(not otherwise specified)
    Indication: Blood Disorder
    Start date: 2005-04-01

Zemaira
    Dosage: (60 mg/kg 1x/week,869 mg/20 ml vial;0.08 ml/kg/min(3.7 ml/min.) intravenous(not otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2005-04-01

Other drugs received by patient: Sodium Chloride; Heparin; Symbicort; Albuterol; Oxygen; Protonix; Vitamin D; Aspirin; Spiriva; Singulair



Possible Zemaira side effects in 74 year old female

Reported by a physician from United States on 2012-01-12

Patient: 74 year old female, weighing 69.9 kg (153.7 pounds)

Reactions: Pruritus, Urticaria, Rash, Kidney Infection

Drug(s) suspected as cause:
Zemaira

Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2007-05-21

Zemaira
    Dosage: see image
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2007-05-21

Other drugs received by patient: Prednisone TAB; Evista; Lorazepam; Doxepin HCL; Theo-24 ER (Theophylline); Allegra; Multivitamin (Accomin Multivitamin); Pataday (Olopatadine Hydrochloride); Lisinopril; Qvar 40; Kenalog; Potassium Chloride; Furosemide; Actonel; Albuterol; Calcium Carbonate; Heparin; Prevacid; Theratears (Carmellose)



Possible Zemaira side effects in 56 year old male

Reported by a physician from United States on 2012-01-06

Patient: 56 year old male, weighing 70.3 kg (154.7 pounds)

Reactions: Myalgia, Syncope, Bone Pain, Dizziness, Feeling Abnormal, Chest X-RAY Abnormal, Loss of Consciousness, Infusion Related Reaction

Drug(s) suspected as cause:
Zemaira

Zemaira
    Dosage: (intravenous (not otherwise specified)), (60 mg/kg 1x/week, approx. 30-60 minutes; 0.08 ml/kg/min (5
    Indication: Obstructive Airways Disorder
    Start date: 2011-03-25

Zemaira
    Dosage: (intravenous (not otherwise specified)), (60 mg/kg 1x/week, approx. 30-60 minutes; 0.08 ml/kg/min (5
    Indication: Obstructive Airways Disorder
    Start date: 2011-11-04
    End date: 2011-11-04

Zemaira
    Dosage: (intravenous (not otherwise specified)), (60 mg/kg 1x/week, approx. 30-60 minutes; 0.08 ml/kg/min (5
    Indication: Obstructive Airways Disorder
    Start date: 2011-01-01

Zemaira

Other drugs received by patient: Symbicort; Daliresp; Spiriva; Proventil; Mucinex



Possible Zemaira side effects in male

Reported by a physician from United States on 2011-12-28

Patient: male, weighing 113.4 kg (249.5 pounds)

Reactions: Dyspnoea, Chills, Hypertension, Hyperhidrosis

Drug(s) suspected as cause:
Zemaira

Other drugs received by patient: Centrum Ulta MEN (Centrum / 00554501 / ); Lisinopril; Lipitor (Atorvastain Calcium); Celebrex (Celeboxib); Hydrochlorothiazide; Zyrtec; Banophen (Diphenhydramine Hydrochloride)

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014